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ABSTRACT
Aim: To evaluate kyphoscoliosis patients with chronic hyper-
capnic respiratory failure (CHRF) using the six minute walk
test (6MWT) distance (6MWD) and cardio-pulmonary func-
tion tests.
Method: This prospective cross-sectional study was carried
out in a tertiary training and research hospital in Turkey.
Kyphoscoliosis patients with CHRF on home mechanical ven-
tilation (HMV) followed in a respiratory intensive care unit
(RICU) out-patient clinic were enrolled. Patients’ demograph-
ics were recorded as well as transthoracic echocardiography
(ECHO), 6MWD, spirometry, arterial blood gas (ABG) values
and high resolution chest computed tomography. 6MWT
results were compared with other parameters.
Results: Thirty four patients with kyphoscoliosis and chronic
respiratory insufficiency admitted to our outpatient clinic
were included in the study but 25 (17 M) patients underwent
6MWT (8 patients walked with oxygen supplement due to
PaO2 < 60 mm Hg). The mean 6MWD was 274.4 ± 76.2 (medi-
an 270) m and median 6MWD predicted rate was 43.7%
(inter quartile ratio, IQR, 37.6% to 47.7%). Median HMV use
was 3 years (IQR 2-4). 6MWD predicted rate, body mass index
(BMI), HMV duration were similar in male and female
patients. 6MWD correlated well with age, BMI, dyspnea score
for baseline 6MWT (r: - 0.59, p < 0.002, r: - 0.58, p < 0.003, 
r: - 0.55, p < 0.005 respectively) but modestly with forced
expiratory volume in one second, pulse rate for baseline
6MWT, pulse saturation rate, fatigue and dyspnea score at
end of 6MWT (r: - 0.44, p < 0.048; r: 0.44, p < 0.027; r: - 0.43,
p < 0.031; r: - 0.42, p < 0.036; r: - 0.42, p < 0.034 respectively).
6MWD predicted rate was only correlated with dyspnea score
at baseline (r: - 0.46, p < 0.022). The systolic pulmonary arte-
rial pressure (PAPs) in 6 (24%) cases was more than 40mmHg,
in whom mean PaO2/FiO2 was 301.4 ± 55.4 compared to
280.9 ± 50.2 in those with normal PAPs (p > 0.40).
Conclusion: The 6MWT is an easy way to evaluate physical
performance limitation in kyphoscoliosis patients with
chronic hypercapnic respiratory failure using home mechani-
cal ventilation. Nearly 275 m was the mean distance walked
in the 6MWT, but rather than distance in meters, the 6MWD
predicted rate according to gender and body mass index
equation might be a better way for deciding about physical
performance of these patients. Dyspnea score at baseline
before the 6MWT may be the most important point that
affects 6MWD in this patient population. 
Keywords: Chronic respiratory failure, home mechanical ven-
tilation, kyphoscoliosis, six-minute walk distance.
RIASSUNTO 
Scopo: Valutare pazienti con cifoscoliosi ed insufficienza respi-
ratoria cronica ipercapnica (CHRF) mediante test del cammino
di 6 minuti (6MWT) e prove di funzionalità cardio-respiratoria.
Metodi: Studio prospettico traversale effettuato in un centro
ospedaliero di training ed insegnamento di terzo livello in
Turchia. Sono stati arruolati pazienti con CHRF in ventilazione
meccanica domiciliare (HMV) seguiti ambulatorialmente dal
reparto di terapia intensiva respiratoria. Sono stati rilevati i
dati demografici, l’ecocardiogramma transtoracico (ECHO), la
distanza coperta nel 6MWT (6MWD), la spirometria, l’emoga-
sanalisi ed una tomografia assiale computerizzata ad alta ri-
soluzione. I risultati del 6MWT sono stati comparati con gli al-
tri parametri.
Risultati: 34 pazienti con cifoscoliosi e insufficienza respirato-
ria cronica sono stati inclusi nello studio, ma solo 25 pazienti
(17 M) hanno effettuato il 6MWT (8 pazienti con supplemen-
to di O2 per PaO2 <60 mm Hg). La 6MWD media era 274 ± 76
(mediana 270) m, pari al 43% del teorico (IQR 37,6-47,7%). I
pazienti erano in HMV da 3 anni (valore mediano, IQR 2-4). I
pazienti dei due sessi non differivano per 6MWD teorico, indi-
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ce di massa corporea, durata della HMV. La 6MWD mostrava
una buona correlazione con età, BMI, punteggio della dispnea
basale al 6MWT (r: - 0,59, p < 0,002; r: - 0,58, p < 0,003; 
r: - 0,55, p < 0,005 rispettivamente), più modesta con il volu-
me espiratorio forzato in 1 secondo (FEV1), frequenza cardia-
ca basale al 6MWT, frequenza alla pulsossimetria, punteggi di
fatica e dispnea al termine del 6MWT (r: - 0,44, 
p < 0,048; r: 0,44, p < 0,027; r: - 0,43, p < 0,031; r: - 0,42, p <
0,036; r: - 0,42, p < 0,034 rispettivamente). Il valore di 6MWD
teorico correlava solo con il punteggio di dispnea prima del
test (r: - 0,46, p < 0,022). La pressione polmonare sistolica era
superiore a 40 mmHg in 6 casi (24%) che presentavano una
PaO2/FiO2 di 301 ± 55 mmHg rispetto a 281 ± 50 in coloro che
avevano valori normali (p > 0,40).
Conclusioni: Il 6MWT è un metodo semplice per valutare le li-
mitazioni di performance fisica nei pazienti con cifoscoliosi e
insufficienza respiratoria cronica ipercapnica in ventilazione
meccanica a lungo termine. La distanza media coperta al
6MWT era circa 275 m, ma più che la distanza assoluta, il teo-
rico della 6MWD corretta per sesso ed indice di massa corpo-
rea può essere un metodo più accurato per valutare la perfor-
mance fisica di questi pazienti. Il punteggio della dispnea pri-
ma del 6MWT può essere il miglior predittore della 6WMD in
questa popolazione di pazienti.
Parole chiave: Cifoscoliosi, insufficienza respiratoria cronica, te-
st del cammino di 6 minuti, ventilazione meccanica domiciliare. 
INTRODUCTION
Kyphoscoliosis (KS) can lead to chronic respiratory
failure (CRF) due to deformity of the chest wall
structure. With aging, chest wall compliance
decreases [1], and the changing breathing pattern
can lead to hypercapnia and hypoxemia [2],
although some KS patients have hypoxemia without
hypercapnia in moderate to severe disease [2,3].
Exercise limitation is often present in patients with
KS although they have a normal breathing pattern
response to exercise and a normal maximum tidal
volume to vital capacity ratio [4]. Kesten and
coworkers [4] showed that exercise intolerance
may be a result of physical deconditioning. The 6-
minute walking test (6MWT) is a simple exercise
test to assess the functional status of patients with
obstructive and restrictive diseases [5] and a good
predictor of mortality in COPD [6,7], pulmonary
hypertension [8] and interstitial lung diseases [9]. To
date there is little data available for the 6-minute
walk distance (6MWD) in patients with KS-CRF and
they do not include a comparison with cardiac
function and patients’ perception of dyspnea (i.e.
Borg scale) [9,10]. However, in few studies were
the shuttle walking test or maximal cycle testing
used to examine performance in these patients
[11,12]. In the present study we aimed to evaluate
6MWD and dyspnea perceptions (modified Borg
scale) [13] and cardio-pulmonary function testing
in patients with KS-CRF. Some data were presented
at the 2009 ERS Congress as an abstract [14].
MATERIALS AND METHODS
This study was performed in accordance with the
Helsinki Declaration. Informed consent was
obtained from patients enrolled in the study. The
study was designed as a prospective cross-sectional
study in a large pulmonary diseases-based tertiary
training and research hospital in Istanbul, Turkey.
Patients: During a 7-year period (2001–2008) of
our program for long-term mechanical ventilation,
we prospectively evaluated our 35 patients with
idiopathic severe kyphoscoliosis, of whom 25
patients (17 male) underwent the 6MWT and were
included in the present study. They had been on
mechanical ventilation (non-invasively or invasively
via tracheostomy cannula) due to hypercapnia
(PaCO2 ≥ 45 mm Hg). Patient characteristics, venti-
lator type, settings (inspiratory, IPAP, and expiratory
positive airway pressure, EPAP) were recorded. 
Measurements: Arterial blood gases (ABGs) (Bayer
Rapidlab 348) were measured in patients at rest,
seated, and breathing room air. Patients’ oxygena-
tion was defined as a ratio of PaO2 to fractioned
inspired oxygen rate (FiO2). Spirometry (ZAN-
GPI.3.00) was performed according to American
Thoracic Society (ATS) guidelines [15]. The 6MWT
was measured using the best of two tests performed
at least 30 min apart as recommended by ATS
guidelines for 6MWT [16]. The test was performed
in a 39-meter long corridor under the supervision of
a pulmonary physician and results were recorded in
meters and in percent of predicted (% pred) as
Enright and co-workers suggest [17]. If PaO2 was 60
mm Hg or resting pulse oxygen saturation (SpO2)
was 90% on room air, patients were not considered
eligible for analysis of oxygen desaturation during
the 6MWT. In this study, desaturation was defined
as a fall in SpO2 below 90% or as a 4% decrease
from the baseline saturation maintaining a SaO2
from 90 to 94%. Transthoracic echocardiography
(ECHO) (Vivid 5 GE Healthcare) was performed by
a cardiologist to define pathology of cardiac func-
tions and measure systolic pulmonary arterial pres-
sure (PAPs) indirectly via the presence of tricuspid
insufficiency. Lung high resolution computerized
tomography (L-HRCT) (Siemens Somatom Spirit)
was performed in our hospital to detect pathology
in lung parenchyma. We defined “normal L-HRCT”
if there was no pathology, and “abnormal L-HRCT”
as the presence of bronchiectesis, tuberculosis
sequel, or emphysema.
Statistical analysis
Descriptive analysis was performed to define the
demographics of the study population. Data are
presented as mean ± SD or numbers and percent-
ages when appropriate. Continuous variables were
summarized using mean and standard deviation for
normal-distributed variables and median for non-
normally distributed variables. Spearman’s rank
correlation test was used to correlate patient char-
acteristics, respiratory functions for 6MWD (meters)
and gender-specific regression equations for
6MWD rate [17]. The Mann-Whitney U test was
used, dividing patients according to 6MWD value
above or below 204 m, to compare patients’ char-






























9 Statistical analysis was performed using SPSS ver-
sion 16.0 and the results were considered statisti-
cally significant at a level of p < 0.05.
RESULTS
Twenty-five out of 34 patients with severe KS and
chronic hypercapnic respiratory failure (CHRF) on
home mechanical ventilation (HMV) (17 male)
underwent the 6MWT and were followed till the
end of study. All patient characteristics, HMV and
oxygen devices, usage year, pressure setting levels,
ABG values, spirometry parameters, measurement
of systolic pulmonary artery pressure (PAPs) greater
than 40 mm Hg by transthoracic ECHO results are
summarized in Table I. 
The median age of patients was 51 years old
(interquartile ratio, 44-58) and male gender was
predominant (68%). The majority of patients were
overweight and obese: 7 patients (28%) with BMI =
25-29 kg/m2 and 10 patients (40%) with BMI > 30
kg/m2. Spirometry results showed that the majority
of patients (n = 19, 76%) had severe airflow
obstruction with restriction. Real time ABGs analy-
sis revealed that 80% (n = 20) of patients were
hypercapnic; the remaining five patients were
hypercapnic when quitting the HMV device. The
majority of patients were hypoxemic; only 8
patients (32%) had PaO2/FiO2 greater than 300 and
8 patients (32%) used oxygen supplementation due
to PaO2 < 60 mm Hg or SpO2 < 90%. All patients
had HMV devices (68% bi-level PAP/ST, 32% bi-
level PAP/S) but 18 (72.0%) KS-CHRF were on long
term oxygen devices at home. Follow up duration of
patients was 1 to 9 years. Only two patients were
ventilated via tracheostomy tube intermittently.
Pathology on L-HRCT was observed in 76% (n = 19)
of patients (3 TB sequaelae, 5 emphysema, 11
bronchiectasis with emphysema). Six patients (24%)
had higher PAPs (> 40 mm Hg) and they all had nor-
mal left ventricular function (ejection fraction >
65%). L-HRCT showed no parenchymal abnormali-
ties in half of the patients with PAH without LTOT (n
= 3, 50%). 
The results of the modified Borg scales [18] before
and after 6MWT, and 6MWD results are summa-
rized in Table II.
Mean 6MWD was nearly 275 m (274.4 ± 76.1 m)
and all KS had less than half the value of gender-
specific regression equations for 6MWD rate [17].
Correlations of patient characteristics, respiratory
functions for 6MWD and gender-specific regression
equations for 6MWD rate [17] in kyphoscoliosis
patients with chronic respiratory failure are summa-
rized in Table III. Body mass index and age were
significantly negatively correlated with 6MWD 
(r: - 0.576, p < 0.003; r. - 0.590, p < 0.002 respec-
tively). Only forced expiratory volume in one sec-
ond, liter (FEV1, L) among spirometry results 
was weakly negatively correlated with 6MWD 
(r: - 0.437, p < 0.048). ABG values were not corre-
lated with 6MWD. Pulse heart rate for baseline test
was weakly significantly correlated with 6MWD 
(r. 0.442, p < 0.027). Pulse oxygen saturation (SpO2)
rate at the end of the 6MWT was negatively weakly
correlated with 6MWD (r: - 0.420, p < 0.036). Borg
TABLE I: PATIENTS’ CHARACTERISTICS AND RESPIRATORY
FINDINGS (N = 25)  
Variables Median (inter quartile ratio)
Age, year 51 (44 to 58)
Gender, male/female 17/8
Body mass index, kg/m2 29 (23 to 31)
HMV duration, year 3 (1.5 to 4.0)
IPAP, cm H2O 18 (12.0 to 21.0)
EPAP, cm H2O 6 (5.0 to 6.0)
LTOT, n (%) 18 (72)
FEV1, L 0.73 (0.7 to 0.85)
FEV1, % predicted 28.0 (25.0 to 34.0)
FVC, L 0.87 (0.72 to 0.95)
FVC, % predicted 27.0 (24.0 to 34.0)
FEV1/FVC, % 84.0 (76.0 to 90.5)
Pathologic lung HRCT, n (%) 19 (76)
PaO2/FiO2, mm Hg 283.3 (256.8 to 316.4)
PaO2, mm Hg 60.0 (54.3 to 67.6)
pH 7.39 (7.37 to 7.42)
PaCO2, mm Hg 51.0 (46.5 to 57.8)
HCO3, mmol/L 30.2 (27.4 to 33.0)
SaO2, % 91.0 (87.4 to 93.9)
Systolic PAP > 40 mm Hg, n (%) 6 (24)
Definition of abbreviations: EPAP, expiratory positive airway pressu-
re; FEV1, forced expiratory volume in one second; FVC, forced vital
capacity; HCO3, bi-carbonate; HMV, home mechanical ventilation;
HRCT, high resolution computerized tomography; IPAP, inspiratory
positive airway pressure; LTOT, long term oxygen therapy; PaO2/FiO2,
partial arterial oxygen pressure over fractionated inspired oxygen;
PaCO2, partial arterial carbon dioxide pressure; PAP, pulmonary arte-
rial pressure; SaO2%, arterial blood oxygen saturation rate.
TABLE II: SIX-MINUTE WALK TEST RESULTS   
Variables Median (inter quartile ratio)
Heart rate/min, baseline 86 (81.5 to 96.0)
Heart rate/min, end of test 123 (116.0 to 136.5)
SpO2%, baseline 93 (92.0 to 95.5)
SpO2%, end of test 76 (70.0 to 86.0)
Oxygen supplement during test, n (%) 8(32)
Borg scale score for fatigue, baseline 0 (0 to 1)
Borg scale score for fatigue, end of test 3 (1.5 to 5.5)
Borg scale score for dyspnea, baseline 0 (0 to 0)
Borg scale score for dyspnea, end of test 5 (2.0 to 7.0)
6MWD, m 270 (202 to 330)
6MWD, % predicted 43.7(37.6 to 47.7)
References equation [17] 6MWD, m 630.1 (575.1 to 685.8)
References of lower level limit  483.9 (427.4 to 541.0)
6MWD, m
Definition of abbreviations: 6MWD, six minute walk distance;
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scale scores for dyspnea at baseline and end of the
6MWT were significantly negatively correlated with
6MWD (r: - 0.548, p > 0.005, r: - 0.425, p < 0.034
respectively) (Table III). Gender specific equations
for 6MWD rate were significantly negatively corre-
lated with Borg dyspnea score at baseline of 6MWT
(r: - 0.457, p < 0.22).
DISCUSSION
The present study revealed that our patients with
severe KS-CHRF walked nearly 270 m in the
6MWT, which was less than half the rate predicted
and the sensation of dyspnea at baseline 6MWT
was an important symptom that affected the
6MWD. 
KS-CHRF is a rare disorder and it is difficult to carry
out a prospective study in a large population sam-
ple. Our sample size (n = 25) was similar to those
of other studies carried out on patients with KS-
CHRF (n = 24 to n = 27) [11,12]. Chest wall com-
pliance decreases with age, and work of breathing
and risk of respiratory muscle fatigue further
increase in elderly patients [1]. Enright and co-
workers made an equation for gender, arm span,
body weight for 6MWD [17]; we analyzed our
results according to both 6MWD (meters) and as a
percentage of the 6MWD predicted rate. We
showed that age and body mass index were not cor-
related to the 6MWD predicted rate although both
correlated significantly to 6MWD (Table III).
Our patients’ spirometry results revealed that nearly
all of them had very limited lung function (severe
restriction and obstruction) and the severity of lung
function did not affect the 6MWD outcome. López-
Campos et al. [11] and Cejudo et al. [12] studied
the shuttle walking test (SWT) and maximal cycle
ergometry test (CET) to assess the functional capac-
ity in patients with KS-CHRF and disease-specific
health-related quality of life (HRQoL). The severity
of lung function was similar to that of our sample
although their patients were older and less hyper-
capnic, but those authors did not use the 6MWT.
The mean 6MWD is well established in patients
with severe COPD-CHRF [6] but not in KS-CHRF. In
the present study we focused on the 6MWD prima-
rily in that specific patient group. Recently
Budweiser and co-workers [10] studied the 6MWT
to predict mortality by collecting data retrospective-
ly in 424 patients treated with non invasive ventila-
tion (NIV) due to CHRF (197 COPD, 112 restrictive
diseases, 115 obesity hypoventilation syndromes).
In that study [10], median 6MWD in patients with
restrictive diseases (n = 112, including 77 chest wall
diseases, 22 neuromuscular diseases and 15 inter-
stitial lung diseases) was 290 m (quartiles 204 to
362) but the exact number of kyphoscoliosis
patients among the group of 77 with chest wall dis-
eases was not clear and their ABG values were
slightly better (median PaCO2 44 mmHg, quartiles
40 to 47 and PaO2 62 mmHg, quartiles 57 to 68). In
the same study the authors claimed that 204 m was
TABLE III: CORRELATIONS OF PATIENT CHARACTERISTICS, RESPIRATORY FUNCTIONS WITH 6MWD AND GENDER-SPECIFIC
REGRESSION EQUATIONS FOR 6MWD RATE   
Variables 6MWD, m 6MWD pred% [17]
R p r P 
Body mass index, kg/m2 -0.576 0.003 -0.266 0.200
Age, year -0.590 0.002 -0.005 0.981
FEV1,L 0.134 0.564 0.188 0.413
FEV1, % pred -0.437 0.048 0.059 0.800
FVC, L 0.052 0.823 0.171 0.457
FVC, % pred -0.412 0.063 0.115 0.620
FEV1/FVC, % 0.163 0.481 -0.096 0.678
PaO2/FiO2, mm Hg 0.114 0.587 0.081 0.700
PaCO2, mm Hg 0.012 0.956 -0.132 0.528
Pulse heart rate, baseline 0.442 0.027 0.044 0.836
Pulse heart rate, end of test 0.150 0.475 -0.097 0.644
SpO2, baseline -0.278 0.178 -0.286 0.166
SpO2, end of test -0.432 0.031 -0.214 0.305
Fatigue score, baseline -0.256 0.216 -0.291 0.158
Fatigue score, end of test -0.420 0.036 -0.243 0.242
Dyspnea score, baseline -0.548 0.005 -0.457 0.022
Dyspnea score, end of test -0.425 0.034 -0.363 0.074
Spearman’s Rank Correlation test was performed. 
Definition of abbreviations: 6MWD, six-minute walking distance; FEV1, forced expiratory volume in one second; FVC, forced vital capacity;































9 a critical value for mortality in patients with restric-
tive lung diseases [10]. We also further analyzed
patients and divided them into two groups accord-
ing to results of 6MWD above and equal to or
below 204 meter. Although patients walking more
than 204 m had more obstructive airway functions,
they had a better fatigue and dyspnea score at the
end of 6MWT (Table IV). More studies are needed
to analyze survival and the 6MWT among this spe-
cific patient group. A higher dyspnea score at base-
line 6MWT may be an important alarm for mortality
to physicians. 
In the present study, the real time ABGs during the
6MWT and other measurements including cardiac
functions were assessed. Our patients, although
younger than those of Budweiser’s study, walked a
shorter distance (median 6MWT distance 270 m,
quartiles 202 to 330). Although exercise intolerance
may be a result of physical deconditioning [4], the
distance walked on the 6MWT can be an easy test
for understanding patients’ perception of dyspnea
and physical performance. 
CONCLUSIONS
In conclusion, the 6MWT is an easy way to evaluate
physical performance limitation in kyphoscoliosis
patients with chronic hypercapnic respiratory fail-
ure using home mechanical ventilation. Nearly 275
m was the mean distance walked in the 6MWT, but
rather than distance in meters, the 6MWD predict-
ed rate according to gender and body mass index
equation might be a better way for deciding about
physical performance of these patients. Dyspnea
score at baseline before the 6MWT may be the most
important point that affects 6MWD in this patient
population. 
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TABLE IV. COMPARISON OF PATIENTS ACCORDING TO 6MWD (ABOVE vs. BELOW 204 METERS)   
Variables Groups according to 6MWD 204 meter p
median (quartiles 25% to 75%)
204 m and lower, n = 8 205 m and higher, n = 17
Gender, male/female 3/5 14/3 0.025
Age, year 55 (52 to 65) 46 (42 to 53) 0.013
Body mass index, kg/m2 32 (32 to 34) 27 (20 to 29) 0.000
FEV1, L 0.76 (0.58 to 0.98) 0.70 (0.59 to 0.77) 0.447
FEV1,% pred 35.0 (29.5 to 49.5) 25.0 (22.0 to 32.0) 0.006
FVC, L 0.90 (0.69 to 1.23) 0.82 (0.78 to 0.97) 0.562
FVC, % pred 33.5 (26.5 to 53.5) 26.0 (24.0 to 29.0) 0.038
FEV1/FVC, % 83.0 (76.0 to 92.0) 84.0 (77.0 to 90.0) 0.856
PaO2/FiO2, mm Hg 289 (243 to 319) 279 (258 to 316) 0.816
pH 7.39 (7.37 to 7.40) 7.41 (7.38 to 7.43) 0.218
PaCO2, mm Hg 49.1 (42.8 to 58.4) 51.0 (48.3 to 57.7) 0.382
HCO3, mmol/L 27.7 (26.8 to 32.0) 30.2 (28.8 to 34.2) 0.165
SaO2, % 91.8 (85.0 to 93.6) 90.3 (88.6 to 93.7) 0.907
6MWD, meter 190 (180 to 197) 300 (270 to 351) 0.000
6MWD, % predicted 35.1 (30.5 to 42.2) 45.9 (43.3 to 52.7) 0.003
Pulse heart rate/min, baseline 82 (74 to 88) 88 (83 to 100) 0.210
Pulse heart rate/min, end of test 124 (108 to 136) 123 (117 to 132) 0.610
SpO2%, baseline 94 (92 to 96) 92 (92 to 95) 0.220
SpO2%, end of test 88 (73 to 93) 73 (70 to 82) 0.061
Fatigue score, baseline 0 (0 to 2) 0 (0 to 0) 0.068
Fatigue score, end of test 6 (3 to 7) 3 (0 to 4) 0.005
Dyspnea score, baseline 1 (0 to 2) 0 (0 to 0) 0.026
Dyspnea score, end of test 7 (6 to 8) 4 (2 to 5) 0.012
Definition of abbreviations: 6MWD, six minute walk distance; SpO2, pulse oxygen saturation rate. 
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